120 related articles for article (PubMed ID: 7650534)
1. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
Szelies B; Mielke R; Grond M; Heiss WD
J Neurol Sci; 1995 May; 130(1):77-81. PubMed ID: 7650534
[TBL] [Abstract][Full Text] [Related]
2. Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.
Fruehwirt W; Dorffner G; Roberts S; Gerstgrasser M; Grossegger D; Schmidt R; Dal-Bianco P; Ransmayr G; Garn H; Waser M; Benke T
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():31-38. PubMed ID: 30582941
[TBL] [Abstract][Full Text] [Related]
3. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Kessler J; Herholz K; Grond M; Heiss WD
Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
[TBL] [Abstract][Full Text] [Related]
4. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
[TBL] [Abstract][Full Text] [Related]
5. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.
Mielke R; Kessler J; Fink G; Herholz K; Heiss WD
Int J Neurosci; 1995 May; 82(1-2):1-9. PubMed ID: 7591506
[TBL] [Abstract][Full Text] [Related]
7. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
11. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
Cutler NR
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218
[TBL] [Abstract][Full Text] [Related]
12. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
[TBL] [Abstract][Full Text] [Related]
13. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
[TBL] [Abstract][Full Text] [Related]
14. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
15. PET and P300 relationships in early Alzheimer's disease.
Marsh JT; Schubarth G; Brown WS; Riege W; Strandburg R; Dorsey D; Maltese A; Kuhl D
Neurobiol Aging; 1990; 11(4):471-6. PubMed ID: 2381507
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
19. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
[TBL] [Abstract][Full Text] [Related]
20. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease.
Kessler J; Mielke R; Grond M; Herholz K; Heiss WD
Int J Neurosci; 2000; 104(1-4):1-15. PubMed ID: 11011970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
